Annual CFI
-$33.83 M
-$33.83 M-100.00%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual cash flow from investing activities is currently -$33.83 million, with the most recent change of -$33.83 million (-100.00%) on 31 December 2023.BLACU Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$150.00 K
-$17.35 M-100.87%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly cash flow from investing activities is currently -$150.00 thousand, with the most recent change of -$17.35 million (-100.87%) on 30 September 2024. Over the past year, it has dropped by -$36.53 million (-100.41%). BLACU quarterly CFI is now -100.41% below its all-time high of $36.38 million, reached on 31 December 2023.BLACU Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$53.31 M
-$150.00 K-0.28%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit TTM cash flow from investing activities is currently $53.31 million, with the most recent change of -$150.00 thousand (-0.28%) on 30 September 2024. Over the past year, it has increased by +$87.14 million (+257.59%). BLACU TTM CFI is now -0.28% below its all-time high of $53.46 million, reached on 30 June 2024.BLACU TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -100.4% | +257.6% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
BLACU Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at low | -100.4% | +99.8% | -0.3% | +175.9% | |
| 5 y | 5 years | at low | -100.4% | +99.8% | -0.3% | +175.9% | |
| alltime | all time | <-9999.0% | at low | -100.4% | +99.8% | -0.3% | +175.9% |
Bellevue Life Sciences Acquisit Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$150.00 K(-100.9%) | $53.31 M(-0.3%) |
| June 2024 | - | $17.20 M(<-9900.0%) | $53.46 M(+47.5%) |
| Mar 2024 | - | -$120.00 K(-100.3%) | $36.26 M(-207.2%) |
| Dec 2023 | -$33.83 M | $36.38 M(>+9900.0%) | -$33.83 M(-51.8%) |
| Sept 2023 | - | $0.00(0.0%) | -$70.21 M(0.0%) |
| June 2023 | - | $0.00(-100.0%) | -$70.21 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$70.21 M(<-9900.0%) | -$70.21 M(<-9900.0%) |
| Dec 2022 | $0.00 | - | - |
| Dec 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00 | $0.00 |
FAQ
- What is Bellevue Life Sciences Acquisit annual cash flow from investing activities?
- What is the all time high annual CFI for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly CFI year-on-year change?
- What is Bellevue Life Sciences Acquisit TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit TTM CFI year-on-year change?
What is Bellevue Life Sciences Acquisit annual cash flow from investing activities?
The current annual CFI of BLACU is -$33.83 M
What is the all time high annual CFI for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual cash flow from investing activities is $0.00
What is Bellevue Life Sciences Acquisit quarterly cash flow from investing activities?
The current quarterly CFI of BLACU is -$150.00 K
What is the all time high quarterly CFI for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly cash flow from investing activities is $36.38 M
What is Bellevue Life Sciences Acquisit quarterly CFI year-on-year change?
Over the past year, BLACU quarterly cash flow from investing activities has changed by -$36.53 M (-100.41%)
What is Bellevue Life Sciences Acquisit TTM cash flow from investing activities?
The current TTM CFI of BLACU is $53.31 M
What is the all time high TTM CFI for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high TTM cash flow from investing activities is $53.46 M
What is Bellevue Life Sciences Acquisit TTM CFI year-on-year change?
Over the past year, BLACU TTM cash flow from investing activities has changed by +$87.14 M (+257.59%)